BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
FDA approves Wegovy pill for weight loss: What to know - 2Man Charged for Stealing ‘Incredibly Precious’ 286-Year-Old Violin, Worth More Than $200,000, from a Tavern
- 3Which Breakfast Enraptures Your Taste Buds? Vote
- 4This Canadian crater looks like marbled meat | Space photo of the day for Jan. 6, 2026
- 5Israel's ban on unsupervised reporters in Gaza causes strategic harm to legitimacy
- From Overpowered to Coordinated: Individual Accounts of Cleaning up
- More Than 110 New Species Discovered In Deep Waters Off Australia
- Taco Bell debuts its Baja Blast pie, and the reactions may surprise you
- 6 Exceptionally Appraised Summer Travel Objections
- NASA loses contact with its Maven spacecraft orbiting Mars for the past decade
- Before trips to Mars, we need better protection from cosmic rays
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- Could it be said that you are As yet Utilizing Old Tires? at These 6 Tire Brands
- NASA's Artemis astronauts enter final preparations for Moon mission
